PATENT CLAIM ANALYSIS

Application Number: 16246876
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "210100"]

Abstract:
An influenza vaccine comprising an influenza hemagglutinin-containing antigen which is subjected to a treatment at a suitable low pH or other suitable conditions to obtain a suitable degree of loss of potency, and the method of making it are provided. The vaccine not only induces an increased cross-reactive immune response and cross protection, but can also induce a strain-specific immune response and protection like current inactivated vaccines. A method of administering influenza vaccines is also provided to induce an increased cross-reactive immune response and cross protection, which is especially suitable for use in emergency situations such as a pandemic.

Claim (Index 35):
The method of  claim 32 , wherein said antigen is a live virus, and said live virus is inactivated after said treatment.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.64062
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15331513', '13993862', '13003570', '13734886', '15256119']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7190390672429083
- 35 USC 102 Novelty (BERT): 0.5373498486540186
- Combined Prediction Score: 0.7008701453840194
- Mean Citation Score: 369.963392
- Max Citation Score: 382.0867
- Similarity Product: 193.32069588026403

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test